| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0190-9622(95)90035-7 |
| P698 | PubMed publication ID | 7601928 |
| P2093 | author name string | B Berman | |
| H C Bieley | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 117-123 | |
| P577 | publication date | 1995-07-01 | |
| P1433 | published in | Journal of the American Academy of Dermatology | Q15757046 |
| P1476 | title | Keloids | |
| P478 | volume | 33 |
| Q36495009 | A case of unilateral keloid after bilateral breast reduction |
| Q36240503 | A comparative clinical study on role of 5-flurouracil versus triamcinolone in the treatment of keloids |
| Q77631558 | A light microscopic and immunohistochemical evaluation of scars |
| Q34743644 | Acquired ear defects |
| Q102379260 | Complex fibroblast response to glucocorticoids may underlie variability of clinical efficacy in the vocal folds |
| Q75222593 | Cryotherapy modifies synthetic activity and differentiation of keloidal fibroblasts in vitro |
| Q46118710 | Differential apoptosis markers in human keloids and hypertrophic scars fibroblasts. |
| Q41870389 | Eradication of keloids: Surgical excision followed by a single injection of intralesional 5-fluorouracil and botulinum toxin |
| Q35085228 | Fibroproliferative scars |
| Q41948246 | Giant keloid of left buttock treated with post-excisional radiotherapy |
| Q38891341 | Glucocorticoids regulate extracellular matrix metabolism in human vocal fold fibroblasts. |
| Q34911441 | Heat shock proteins modulate keloid formation |
| Q24595036 | Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies |
| Q91899208 | In Vitro and Ex Vivo Models for Functional Testing of Therapeutic Anti-scarring Drug Targets in Keloids |
| Q36265560 | Keloidoscope: in search for the ideal treatment of keloids |
| Q34512378 | Keloids: The paradigm of skin fibrosis - Pathomechanisms and treatment |
| Q38459769 | Myofibroblast phenotype and apoptosis in keloid and palmar fibroblasts in vitro |
| Q33193109 | New Therapies for the Management of Keloids |
| Q38637810 | Non-operative treatment of hypertrophic scars and keloids after burns in children |
| Q36239940 | Novel Insights on Understanding of Keloid Scar: Article Review |
| Q73874835 | Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections |
| Q36137666 | Risk factors of keloids in Syrians |
| Q36319281 | Scar evaluation and management: recommendations |
| Q60953210 | Sensitization of keloid fibroblasts by quercetin through the PI3K/Akt pathway is dependent on regulation of HIF-1α |
| Q39126412 | Silk-fibroin-coated liposomes for long-term and targeted drug delivery |
| Q33816932 | Surgery and perioperative intralesional corticosteroid injection for treating earlobe keloids: a korean experience. |
| Q26770100 | The Immunomodulatory Effects of Mesenchymal Stem Cells in Prevention or Treatment of Excessive Scars |
| Q40867502 | The molecular basis of keloid and hypertrophic scar formation |
| Q97422454 | The use of botulinum toxin in keloid scar management: a literature review |
| Q55497467 | Time Heals all Wounds- but Scars Remain. Can Personalized Medicine Help? |
| Q47955372 | Treatment of Keloids by Surgical Excision and Immediate Postoperative Single-Fraction Radiotherapy |
| Q81735085 | [Keloid and hypertrophic scar] |
Search more.